154 related articles for article (PubMed ID: 15811592)
1. Neuronal inclusions in degenerative disorders Do they represent static features or a key to understand the dynamics of the disease?
Fornai F; Soldani P; Lazzeri G; di Poggio AB; Biagioni F; Fulceri F; Batini S; Ruggieri S; Paparelli A
Brain Res Bull; 2005 Apr; 65(4):275-90. PubMed ID: 15811592
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of NEDD8 in neuronal and glial inclusions of neurodegenerative disorders.
Mori F; Nishie M; Piao YS; Kito K; Kamitani T; Takahashi H; Wakabayashi K
Neuropathol Appl Neurobiol; 2005 Feb; 31(1):53-61. PubMed ID: 15634231
[TBL] [Abstract][Full Text] [Related]
3. The DNA repair-ubiquitin-associated HR23 proteins are constituents of neuronal inclusions in specific neurodegenerative disorders without hampering DNA repair.
Bergink S; Severijnen LA; Wijgers N; Sugasawa K; Yousaf H; Kros JM; van Swieten J; Oostra BA; Hoeijmakers JH; Vermeulen W; Willemsen R
Neurobiol Dis; 2006 Sep; 23(3):708-16. PubMed ID: 16860562
[TBL] [Abstract][Full Text] [Related]
4. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology.
Braak H; de Vos RA; Bohl J; Del Tredici K
Neurosci Lett; 2006 Mar; 396(1):67-72. PubMed ID: 16330147
[TBL] [Abstract][Full Text] [Related]
5. A proteomic approach to assess intraneuronal inclusions associated with neurodegenerative disorders.
Kawaja MD
Curr Opin Mol Ther; 2005 Dec; 7(6):565-8. PubMed ID: 16370379
[TBL] [Abstract][Full Text] [Related]
6. Cellular pathways leading to neuronal dysfunction and degeneration.
Kazantsev AG
Drug News Perspect; 2007 Oct; 20(8):501-9. PubMed ID: 18080037
[TBL] [Abstract][Full Text] [Related]
7. Influences of intranuclear inclusion on nuclear size - morphometric study on pontine neurons of neuronal intranuclear inclusion disease cases.
Uchihara T; Tanaka J; Funata N; Arai K; Hattori T
Acta Neuropathol; 2003 Feb; 105(2):103-8. PubMed ID: 12536220
[TBL] [Abstract][Full Text] [Related]
8. Limbic structures are prone to age-related impairments in proteasome activity and neuronal ubiquitinated inclusions in SAMP10 mouse: a model of cerebral degeneration.
Shimada A; Keino H; Kawamura N; Chiba Y; Hosokawa M
Neuropathol Appl Neurobiol; 2008 Feb; 34(1):33-51. PubMed ID: 17973906
[TBL] [Abstract][Full Text] [Related]
9. The neurotoxicity of amphetamines: bridging drugs of abuse and neurodegenerative disorders.
Iacovelli L; Fulceri F; De Blasi A; Nicoletti F; Ruggieri S; Fornai F
Exp Neurol; 2006 Sep; 201(1):24-31. PubMed ID: 16678160
[TBL] [Abstract][Full Text] [Related]
10. Neurons and mechanisms of neuronal death in neurodegenerative diseases: a brief review.
Waggie KS; Kahle PJ; Tolwani RJ
Lab Anim Sci; 1999 Aug; 49(4):358-62. PubMed ID: 10480639
[TBL] [Abstract][Full Text] [Related]
11. Protein quality control mechanisms and neurodegenerative disorders: Checks, balances and deadlocks.
Mittal S; Ganesh S
Neurosci Res; 2010 Nov; 68(3):159-66. PubMed ID: 20708043
[TBL] [Abstract][Full Text] [Related]
12. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein.
Giasson BI; Duda JE; Quinn SM; Zhang B; Trojanowski JQ; Lee VM
Neuron; 2002 May; 34(4):521-33. PubMed ID: 12062037
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin proteasome system as a pharmacological target in neurodegeneration.
Hol EM; Fischer DF; Ovaa H; Scheper W
Expert Rev Neurother; 2006 Sep; 6(9):1337-47. PubMed ID: 17009921
[TBL] [Abstract][Full Text] [Related]
14. NSF, Unc-18-1, dynamin-1 and HSP90 are inclusion body components in neuronal intranuclear inclusion disease identified by anti-SUMO-1-immunocapture.
Pountney DL; Raftery MJ; Chegini F; Blumbergs PC; Gai WP
Acta Neuropathol; 2008 Dec; 116(6):603-14. PubMed ID: 18836734
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of neuronal inclusions combined with increased nigral expression of alpha-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in mice.
Fornai F; Lenzi P; Ferrucci M; Lazzeri G; di Poggio AB; Natale G; Busceti CL; Biagioni F; Giusiani M; Ruggieri S; Paparelli A
Brain Res Bull; 2005 May; 65(5):405-13. PubMed ID: 15833595
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms involved in the formation of dopamine-induced intracellular bodies within striatal neurons.
Lazzeri G; Lenzi P; Busceti CL; Ferrucci M; Falleni A; Bruno V; Paparelli A; Fornai F
J Neurochem; 2007 Jun; 101(5):1414-27. PubMed ID: 17286589
[TBL] [Abstract][Full Text] [Related]
17. Evidence for sequestration of polyglutamine inclusions by Drosophila myeloid leukemia factor.
Kim WY; Fayazi Z; Bao X; Higgins D; Kazemi-Esfarjani P
Mol Cell Neurosci; 2005 Aug; 29(4):536-44. PubMed ID: 15936212
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitinated inclusions and neuronal cell death.
Lang-Rollin I; Rideout H; Stefanis L
Histol Histopathol; 2003 Apr; 18(2):509-17. PubMed ID: 12647802
[TBL] [Abstract][Full Text] [Related]
19. Convergent roles of alpha-synuclein, DA metabolism, and the ubiquitin-proteasome system in nigrostriatal toxicity.
Fornai F; Lazzeri G; Bandettini Di Poggio A; Soldani P; De Blasi A; Nicoletti F; Ruggieri S; Paparelli A
Ann N Y Acad Sci; 2006 Aug; 1074():84-9. PubMed ID: 17105905
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical localization of NUB1, a synphilin-1-binding protein, in neurodegenerative disorders.
Tanji K; Mori F; Kakita A; Zhang H; Kito K; Kamitani T; Takahashi H; Wakabayashi K
Acta Neuropathol; 2007 Oct; 114(4):365-71. PubMed ID: 17549501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
